Normal Matrix Mineralization Induced by Strontium Ranelate in MC3T3-E1 Osteogenic Cells

Metabolism: Clinical and Experimental

Volumn 53, Issue 4, 2004, Pages 532-537

  Barbara, A ^b   Delannoy, P ^b   Denis, B G ^b   Marie, P J ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASCORBIC ACID; CALCITRIOL; COLLAGEN; PHOSPHATE; PROLINE; STRONTIUM; STRONTIUM RANELATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE CELL; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; CALCIFICATION; CALVARIA; CELL CULTURE; CELL FUNCTION; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; LONG TERM CARE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SHORT COURSE THERAPY; TISSUE CULTURE;

EID: 1842531000     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.10.022     Document Type: Article

References (46)

1. Marie PJ: Effects of strontium on bone formation and bone cells, in Neve J, Chappuis P, Lamand M (eds): Therapeutic Uses of Traces Elements. New York, NJ, Plenum, 1996, pp 277-282
2. Marie PJ, Ammann P, Boivin G, et al: Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69:121-129, 2001
3. Marie PJ, Garba MT, Hott M, et al: Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab 11:5-13, 1985
4. Marie PJ, Chabot G, Glorieux FH, et al: Histomorphometry of bone changes in human subjects following low dosage of stable strontium, in Hemphill DD (ed): Proceeding of the 19th Annual Conference on Trace Substances in Environmental Health. Columbia, MO, University of Columbia Press, 1985, pp 193-208
5. Marie PJ, Hott M: Short-term effects of fluoride and strontium on bone formation and resorption in the mouse. Metabolism 35:547-551, 1986
6. Grynpas M, Marie PJ: Effects of low doses of strontium on bone quality and quantity in rats. Bone 11:313-319, 1990
7. Matsumoto A: Effect of strontium chloride on bone resorption induced by prostaglandin E2 in cultured bone. Arch Toxicol 62:240-241, 1988
8. Ferraro EF, Carr R, Zimmerman K: A comparison of the effects of strontium chloride and calcium chloride on alveolar bone. Calcif Tissue Int 35:258-260, 1983
9. Canalis E, Hott M, Deloffre P, et al: The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 8:517-523, 1996
10. Baron R, Tsouderos Y: In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450:11-17, 2002
11. Takahashi N, Sasaki T, Tsouderos Y, et al: S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18:1082-1087, 2003
12. Marie PJ, Hott M, Modrowski D, et al: An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607-615, 1993
13. Hott M, Deloffre P, Tsouderos Y, et al: S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 33:115-123, 2003
14. Buehler J, Chappuis P, Saffar JL, et al: Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys. Bone 29:176-179, 2001
15. Shen V, Robin B, Bazot D, et al: Histomorphometric evaluation of the proximal tibia metaphysis after long-term oral administration of S12911 in female rats. J Bone Miner Res 17:S369, 2002 (suppl 1, abstr)
16. Delannoy P, Bazot D, Marie PJ: Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 51:906-911, 2002
17. Meunier PJ, Slosman DO, Delmas PD, et al: Strontium ranelate: Dose-dependent effects in established postmenopausal vertebral osteoporosis. The Stratos 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87:2060-2066, 2002
18. Meunier PJ, Roux C, Ortolani S, et al: Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis. Osteoporos Int 13:O45, 2002 (suppl 1, abstr)
19. Reginster Y, Sawicki A, Devoegelaer JP, et al: Strontium ranelate reduces the risk of HIP fracture in women with postmenopausal osteoporosis. Osteoporos Int 13:O14, 2002 (suppl 3, abstr)
20. Dahl SG, Allain P, Marie PJ, et al: Incorporation and distribution of strontium in bone. Bone 28:446-453, 2001
21. Boivin G, Deloffre P, Perrat B, et al: Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 11:1302-1311, 1996
22. D'Haese PC, Schrooten I, Goodman WG, et al: Increased bone strontium levels in hemodialysis patients with osteomalacia. Kidney Int 57:1107-1114, 2000
23. Schrooten I, Cabrera W, Goodman WG, et al: Strontium causes osteomalacia in chronic renal failure rats. Kidney Int 54:448-456, 1998
24. Schrooten I, Behets GJ, Cabrera WE, et al: Dose-dependent effects of strontium on bone of chronic renal failure rats. Kidney Int 63:927-935, 2003
25. Sudo H, Kodama HA, Amagai Y, et al: In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198, 1983
26. Matsumoto T, Igarashi C, Takeuchi Y, et al: Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 12:27-32, 1991
27. Quarles LD, Yohay DA, Lever LW, et al: Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J Bone Miner Res 7:683-692, 1992
28. Fratzl-Zelman N, Fratzl P, Horandner H, et al: Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. Bone 23:511-520, 1998
29. Wang D, Christensen K, Chawla K, et al: Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893-903, 1999
30. Rowe DW, Kream BE: Regulation of collagen synthesis in fetal rat calvaria by 1,25-dihydroxyvitamin D3. J Biol Chem 257:8009-8015, 1982
31. Marie PJ: Optimizing bone metabolism in osteoporosis: Insight into the pharmacologic profile of strontium ranelate. Osteoporos Int 14:9-12, 2003 (suppl 3)
32. Franceschi RT, Iyer BS: Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7:235-246, 1992
33. Beck GR Jr, Sullivan EC, Moran E, et al: Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 68:269-280, 1998
34. Igarashi K, Hirafuji M, Adachi H, et al: Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1. Prostaglandins Leukot Essent Fatty Acids 50:169-172, 1994
35. Kaji T, Suzuki K, Yoshikawa M, et al: Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch Oral Biol 44:233-241, 1999
36. Kitching R, Qi S, Li V, et al: Coordinate gene expression patterns during osteoblast maturation and retinoic acid treatment of MC3T3-E1 cells. J Bone Miner Metab 20:269-280, 2002
37. Gopalakrishnan R, Ouyang H, Somerman MJ, et al: Matrix gamma-carboxyglutamic acid protein is a key regulator of PTH-mediated inhibition of mineralization in MC3T3-E1 osteoblast-like cells. Endocrinology 142:4379-4388, 2001
38. Spinella-Jaegle S, Roman-Roman S, Faucheu C, et al: Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29:323-330, 2001
39. Sowa H, Kaji H, Yamaguchi T, et al: Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Biol Chem 277:36024-36031, 2002
40. Maeda T, Matsunuma A, Kawane T, et al: Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 280:874-877, 2001
41. Igarashi K, Hirafuji M, Adachi H, et al: Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. Prostaglandins Leukot Essent Fatty Acids 56:121-125, 1997
42. Togari A, Arakawa S, Arai M, et al: Alteration of in vitro bone metabolism and tooth formation by zinc. Gen Pharmacol 24:1133-1140, 1993
43. Ikeda K, Matsumoto T, Morita K, et al: Inhibition of in vitro mineralization by aluminum in a clonal osteoblastlike cell line, MC3T3-E1. Calcif Tissue Int 39:319-323, 1986
44. Miyahara T, Yamada H, Takeuchi M, et al: Inhibitory effects of cadmium on in vitro calcification of a clonal osteogenic cell, MC3T3-E1. Toxicol Appl Pharmacol 96:52-59, 1988
45. Burnell JM, Teubner EJ, Miller AG: Normal maturational changes in bone matrix, mineral, and crystal size in the rat. Calcif Tissue Int 31:13-19, 1980
46. Grynpas MD, Hamilton E, Cheung R, et al: Strontium increases vertebral bone volume in rats at a low dose that does not induce mineralization defect. Bone 18:253-259, 1996